hepatitis-c

Documents about hepatitis-c

• HepATocellular Cancer Hcv Therapy Study#873201ClinicalTrials.gov
• Neutrino Regimen for Treatment-experienced HCV GT1 Patients#884143ClinicalTrials.gov
• HCV-RNA Kinetics During Sorafenib for Hepatocellular Carcinoma (HCC)#915912ClinicalTrials.gov
• Clinical Pharmacology Study of AZD7295 in Healthy Subjects#916325ClinicalTrials.gov
• Community-based Treatment of Chronic Hepatitis C Monoinfection and Coinfection With HIV in the District of Columbia#837993ClinicalTrials.gov
• A Novel Hepatitis c micrOelimination Program in Non imprisonEd SenTenced With Alternative Measures#863509ClinicalTrials.gov
• A Long Term Follow-up Study in Participants Treated in a Preceding Phase 2 or 3 Study With a Regimen Containing Odalasvir and AL-335 With or Without Simeprevir for the Treatment of Hepatitis C Virus (HCV) Infection#894835ClinicalTrials.gov
• A Study to Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced, Non-Cirrhotic Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With or Without Human Immunodeficiency Virus Co-Infection#879759ClinicalTrials.gov
• TMC435-TiDP16-C121: A Study Comparing 2 Tablet Formulations of TMC435 to an Established Capsule Formulation and Evaluating the Effect of Food on Blood Levels of TMC435#813664ClinicalTrials.gov
• TMC435-TiDP16-C125 - Study in Healthy Volunteers to Evaluate the Potential of TMC435 to Increase the Sensitivity of the Skin Towards Exposure to Sun Light#862467ClinicalTrials.gov
• MYPROMS-ES02: Safety and Efficacy of Basiliximab, Cyclosporine Microemulsion and Enteric-coated Mycophenolate Sodium (EC-MPS) Versus EC-MPS and Steroid Therapy in Kidney Transplant Recipients Who Are Hepatitis C Positive#903570ClinicalTrials.gov
• Peginterferon Alfa-2a Plus Ribavirin Plus Amantadine for the Treatment of Hepatitis C Infected Patients#1010143ClinicalTrials.gov
• An entropic safety catch controls Hepatitis C virus entry and antibody resistance#329299Birkbeck Institutional Research Online
• HIV, Age, and the Severity of Hepatitis C Virus–Related Liver Disease#383966CiNii
• EPIDEMIOLOGICAL CHARACTERISTICS AND HEPATITIS C MICRO-ELIMINATION IN CHILDREN: EXPERIENCE OF TOMSK REGION#619402CyberLeninka
• Evaluating the Role of Immune Responses in the Emergence of Protease Inhibitor Mutations#832542ClinicalTrials.gov
• PoC-HCV Genedrive Viral Detection Assay Validation Study#858382ClinicalTrials.gov
• Hepatitis C in Adults Who Underwent Congenital Heart Surgery Before Screening#910313ClinicalTrials.gov
• Building on Needle Exchange to Optimize Prevention & Treatment#911140ClinicalTrials.gov
• Boceprevir (SCH 503034) Plus Peg-Intron, With and Without Added Ribavirin, in Patients With Chronic Hepatitis C, Genotype 1, Who Did Not Respond to Previous Treatment With Peginterferon Alfa Plus Ribavirin (Study P03659AM2)(COMPLETED)#1008854ClinicalTrials.gov
• Plasma-targeted proteomic and lipidomic profiling of MASLD, MASH, and hepatitis C virus infection.#193728NCBI PubMed Central
• Direct-Acting Antiviral Agents in Hepatitis C–Associated Indolent Lymphomas#264880IRIS
• The Danish Database for Hepatitis B and C (DANHEP): A Nationwide, Prospective, Ongoing Cohort Study.#275637NCBI PubMed Central
• Liver reprogramming toward hepatocellular carcinoma following hepatitis C sustained virologic response: a narrative review.#452901NCBI PubMed Central
• A data-driven approach to hepatitis C forecasting using machine learning and epidemiological models.#631089NCBI PubMed Central
• sgp130 in Chronic Human Liver Disease#804318ClinicalTrials.gov
• Chronic Hepatitis C Treatment in Egyptian Children With Gaucher Disease.#812049ClinicalTrials.gov
• SVR12 in Genotype 3 HCV (F0-F2) Treated With RDV + SOF#836659ClinicalTrials.gov
• Effects of Vitamin D on Inflammation in Liver Disease#838799ClinicalTrials.gov
• Sovaldi-based Regimens in Patients in Mexico With Chronic Hepatitis C Virus Infection in Clinical Practice#881280ClinicalTrials.gov
• EPIC: Evaluation of Pharmacy-based Identification and Treatment of HCV#894945ClinicalTrials.gov
• Thalidomide Plus Peginterferon and Ribavirin in Patients With Interferon Resistance#914914ClinicalTrials.gov
• Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination Administered in Patients Infected With Chronic Genotype 1 or 4 HCV for Use in the Peri-Operative Liver Transplantation Setting#891094ClinicalTrials.gov
• Integrated drug resistance action framework for HIV, hepatitis B and C and sexually transmitted infections, 2026–2030#151807WHO IRIS
• Evaluating Pay-It-Forward Strategy to Promote Hepatitis B Virus and Hepatitis C Virus Testing Among International Migrants From Low- and Middle-Income Countries in China: Protocol for a Cluster Randomized Controlled Trial.#219143NCBI PubMed Central
• Raltegravir in Patients With End Stage Liver Disease and in Transplant Recipients#833817ClinicalTrials.gov
• A retrospective cohort data-linkage study of secondary healthcare use prior to late blood-borne virus diagnosis in Scotland – A missed opportunity for earlier diagnosis?#990058STORRE
• Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination, With or Without Ribavirin, in Egyptian Adults With Chronic Genotype 4 HCV Infection#875741ClinicalTrials.gov
• Quantifying the non-medical costs patients incur to access hepatitis C treatment in Southern Vietnam#4921Europe PMC
• Study of Long-term Peg Intron vs. Colchicine in Non-responders.#67753ClinicalTrials.gov
• A novel dimerization site in non-structural protein 5A of hepatitis C virus regulates viral replication fitness#261154bioRxiv / medRxiv
• Virucidal activity of porphyrin-based metal-organic frameworks against highly pathogenic coronaviruses and hepatitis C virus#330215HAL (France)
• Virucidal activity of porphyrin-based metal-organic frameworks against highly pathogenic coronaviruses and hepatitis C virus#330256HAL (France)
• Nicotinamide metabolism is essential for Hepatitis C Virus replication and the production of infectious Lipo-Viro-Particles#344602HAL (France)
• Barriers and facilitators to hepatitis C patient engagement: Interview study with general practitioner champions in England.#360551NCBI PubMed Central
• A Drug Interaction Study of Boceprevir in Combination With Amlodipine or Diltiazem in Healthy Volunteers#414381ClinicalTrials.gov
• Missed opportunities for Hepatitis C Virus screening and care among persons hospitalized for injection-related infections.#472495NCBI PubMed Central
• Increasing Viral Testing in the Emergency Department#813050ClinicalTrials.gov
• Rapid HCV RNA Testing and LInkage to Care#813426ClinicalTrials.gov
• HCV Seek, Test and Rapid Treatment for Young PWID#825298ClinicalTrials.gov